A PHASE 1 TRIAL OF ORAL SRA737 (A CHK1 INHIBIDOR) GIVEN IN COMBINATION WITH GEMCITABINE PLUS CISPLATIN OR GEMCITABINE ALONE IN SUBJECTS WITH ADVANCED CANCER
2015-004467-36TUMOR SÓLIDO HISTOLÓGICAFundación Jiménez DíazInvestigador: MORENO GARCIA VICTOR